T1	Intervention 12 126	shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1
#1	AnnotatorNotes T1	Study the effects of this medicine on acute exacerbated chronic obstructive pulmonary disease patients.
T2	Intervention 594 611	Routine therapies
#2	AnnotatorNotes T2	Routine therapies were given to the control group
T3	Intervention 672 680	15 mL SI
#3	AnnotatorNotes T3	Per treatment group
T4	Intervention 723 778	by intravenous dripping, twice daily for total 14 days.
#4	AnnotatorNotes T4	via treatment group
T5	Intervention 2134 2174	correcting the imbalance of MMP-9/TIMP-1
#5	AnnotatorNotes T5	Via lowering the serum levels of MMP-9 and TIMP-1 could improve pulmonary ventilation function in acute exacerbated COPD patients. 
